Description
Discover the latest insights into Driver Alterations in Lung Cancer with top experts from Southeast Asia in Series III of the IASLC Regional Series. This course will explore molecular profiling, emerging treatments for biomarkers like EGFR and KRAS, advancements in targeted therapies for advanced disease, and strategies for managing brain metastases. Gain valuable knowledge and connect with leaders shaping the future of thoracic oncology!
Image
Learning Objectives
Review the current treatments for patients with oncogenic-driven lung cancer.